Phase II study of combination pembrolizumab and olaparib in patients with advanc
- This topic has 0 replies, 1 voice, and was last updated 2 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Phase II study of combination pembrolizumab and olaparib in patients with advanced cholangiocarcinoma: Interim results.
https://meetings.asco.org/abstracts-presentations/204979
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.